InventHelp Inventor Develops New Mobility Aid (FJK-386)
PITTSBURGH, July 3, 2024 /PRNewswire/ -- "I wanted to create a new mobility aid to reduce weight from being placed on an injured foot, knee, or leg," said an inventor, from Port St. Lucie, Fla., "so I invented the GLIDER SHOE. My design could help reduce pain and increase mobility for users."
The patent-pending invention provides an improved design for a mobility aid. In doing so, it reduces the stress and weight placed upon an injured foot, knee, or leg. As a result, it could increase mobility. It also offers an alternative to using a walker or cane. The invention features a practical design that is easy to use so it is ideal for individuals recovering from an injury or surgery, individuals with a prosthetic leg, etc. Additionally, it is producible in various sizes.
The original design was submitted to the Fort Lauderdale sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 22-FJK-386, InventHelp, 100 Beecham Drive, Suite 110, Pittsburgh, PA 15205-9801, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com.
Team famous for HIV breakthroughs demonstrates both persistent COVID virus and widespread immune activation in long COVID; provides clear targets for treatment
Key points:
SARS-CoV-2 double-stranded RNA indicative of viral replication was found in...
CloudMD Software & Services Inc. (the "Company" or "CloudMD"), an innovative health services company transforming the delivery of care, is pleased to announce that it has received a final order from the Supreme Court of British Columbia approving...
Workers at Watsonville Community Hospital represented by Teamsters Local 853 have voted unanimously to ratify a collective bargaining agreement. The new three-year contract includes significant wage increases, a strong benefits package with Teamsters...
The global anti-inflammatory therapeutics market size is estimated to grow by USD 38.7 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 6.3% during the forecast period. Increase in off-label use is...
Pulse Biosciences, Inc. (the "Company" or "Pulse Biosciences"), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablationtm (nsPFAtm) technology, announced today the closing of its rights offering and the final results...
Reference is made to the stock exchange notice by Aker BioMarine ASA ("AKBM") today regarding the sale of its ownership position in the Feed Ingredients business to a new company to be established ("Aker BioMarine Antarctic Holding II AS") owned 60%...
